Keyphrases
HPV16
100%
Cellular Immune Response
100%
Humoral Immune Response
100%
L1 Protein
100%
Cholera Toxin B
100%
Sublingual Immunization
100%
Secretory Immunoglobulin A (SIgA)
80%
Sublingual Route
80%
Interferon-α (IFN-α)
40%
Sublingual
40%
Intravaginal Route
40%
Transdermal Route
40%
Saliva
20%
Interleukin-4 (IL-4)
20%
Developing Countries
20%
Receptor Agonist
20%
CD4+ T Cells
20%
CD8+ T Cells
20%
Toll-like
20%
Co-treatment
20%
Non-parenteral
20%
Intranasal Route
20%
IgG Response
20%
Route of Administration
20%
Systemic Immune Response
20%
Mucosal Immune Response
20%
Immunogenicity
20%
Serum IgG
20%
Adjuvanticity
20%
Vitamin D3
20%
Poly-γ-glutamic Acid (γ-PGA)
20%
Sublingual Vaccine
20%
Vaccine Administration
20%
Antigen Dose
20%
Intravesical Delivery
20%
Sublingual Administration
20%
Intramuscular Route
20%
Nucleotide-binding Oligomerization Domain
20%
Needle-free
20%
Pharmacology, Toxicology and Pharmaceutical Science
Human Papillomavirus Type 16
100%
Adjuvant
100%
Cholera Toxin B Subunit
100%
Secretory Immunoglobulin
80%
Sublingual Route
80%
Interferon
40%
Transdermal
40%
Interleukin 4
20%
CD8 Antigen
20%
Antigen
20%
Immunogenicity
20%
Polyglutamic Acid
20%
Intramuscular Route
20%
Toll Like Receptor Agonist
20%
Sublingual Administration
20%
Cholecalciferol
20%